Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig I Coleman

Showing results (31-40 of 351) with videos related to

Pageof 36
Sort By:
Current Medical Research and Opinion|June 16, 2015
Derivation and validation of the In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction ruleCraig I Coleman, Christine G Kohn, Thomas J Bunz
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 4, 2004
Atazanavir: a new protease inhibitor to treat HIV infectionBogdan L Musial, Joanna K Chojnacki, Craig I Coleman
The Journal of Clinical Psychiatry|May 6, 2010
The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysisMegan Ehret, John Goethe, Michael Lanosa, et al.
Pharmacotherapy|July 30, 2009
Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysisWilliam L Baker, Erica L Baker, Craig I Coleman
Connecticut Medicine|February 24, 2010
Clopidogrel and proton pump inhibitor use: what does the evidence really say?William L Baker, Craig I Coleman, Justin B Lundbye
The American Journal of Managed Care|December 27, 2011
US prevalence of upper gastrointestinal symptoms: a systematic literature reviewDiana M Sobieraj, Stacey M Coleman, Craig I Coleman
Journal of Clinical Psychopharmacology|January 2, 2013
Effect of topiramate on weight gain in patients receiving atypical antipsychotic agentsShamail Mahmood, Ian Booker, Judy Huang, et al.
Health and Quality of Life Outcomes|June 27, 2013
Estimation of the effect of dalfampridine-ER on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patientsBrendan L Limone, Matthew F Sidovar, Craig I Coleman
Annals of Family Medicine|May 14, 2008
Effect of nonergot dopamine agonists on symptoms of restless legs syndromeWilliam L Baker, C Michael White, Craig I Coleman
Journal of Fungi (Basel, Switzerland)|November 26, 2025
Coccidioidomycosis-Attributable Death in the United States: An Analysis of Cases Reported on Death Certificates, 2018-2023Huiqiao Fan, Fariba Donovan, Belinda Lovelace, et al.
Pageof 36

Showing results (31-40 of 351) with videos related to

Sort By:
Pageof 36
Current Medical Research and Opinion|June 16, 2015
Derivation and validation of the In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction ruleCraig I Coleman, Christine G Kohn, Thomas J Bunz
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 4, 2004
Atazanavir: a new protease inhibitor to treat HIV infectionBogdan L Musial, Joanna K Chojnacki, Craig I Coleman
The Journal of Clinical Psychiatry|May 6, 2010
The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysisMegan Ehret, John Goethe, Michael Lanosa, et al.
Pharmacotherapy|July 30, 2009
Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysisWilliam L Baker, Erica L Baker, Craig I Coleman
Connecticut Medicine|February 24, 2010
Clopidogrel and proton pump inhibitor use: what does the evidence really say?William L Baker, Craig I Coleman, Justin B Lundbye
The American Journal of Managed Care|December 27, 2011
US prevalence of upper gastrointestinal symptoms: a systematic literature reviewDiana M Sobieraj, Stacey M Coleman, Craig I Coleman
Journal of Clinical Psychopharmacology|January 2, 2013
Effect of topiramate on weight gain in patients receiving atypical antipsychotic agentsShamail Mahmood, Ian Booker, Judy Huang, et al.
Health and Quality of Life Outcomes|June 27, 2013
Estimation of the effect of dalfampridine-ER on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patientsBrendan L Limone, Matthew F Sidovar, Craig I Coleman
Annals of Family Medicine|May 14, 2008
Effect of nonergot dopamine agonists on symptoms of restless legs syndromeWilliam L Baker, C Michael White, Craig I Coleman
Journal of Fungi (Basel, Switzerland)|November 26, 2025
Coccidioidomycosis-Attributable Death in the United States: An Analysis of Cases Reported on Death Certificates, 2018-2023Huiqiao Fan, Fariba Donovan, Belinda Lovelace, et al.
Pageof 36